KPRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Kiora Pharmaceuticals Inc (KPRX) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators are bearish, the financial performance shows significant losses, and there are no positive catalysts or trading signals to suggest an imminent turnaround. The lack of news, insider activity, and congress trading data further supports a hold recommendation.
The technical indicators are bearish. The MACD is below 0 and negatively contracting, RSI is neutral at 39.307, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 1.97, with key support at 1.821 and resistance at 2.119.
NULL. No news, insider activity, or congress trading data available.
Bearish technical indicators, declining gross margin (-100% YoY), and significant net losses despite improvement in EPS and net income.
In Q4 2025, the company reported zero revenue growth (0% YoY), a net loss of -$6,516,521 (improved by 54.29% YoY), and an EPS of -1.66 (improved by 66% YoY). Gross margin dropped to 0, indicating no profitability.
No analyst rating or price target changes available.
